Macular OCTA Biomarkers of Ocular Involvement in Patients With Primary Central Nervous System Lymphoma
Hematological Oncology · 2026-11 · 44 (6)
DOI: 10.1002/hon.70289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematological Oncology, online erschienen am 30.10.2026. Verfasst von Tianyu Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms, Tomography, Optical Coherence, Macula Lutea, Lymphoma. Die Arbeit nennt 31 Literaturangaben. Gefördert von: the Natural Science Foundation of Shanghai.
Abstract (Originalsprache)
Ocular involvement in primary central nervous system lymphoma (PCNSL) can be difficult to identify, highlighting the need for noninvasive biomarkers that may support its detection. We investigated optical coherence tomography angiography (OCTA) biomarkers associated with ocular involvement in PCNSL. This retrospective single‐center study included 62 eyes from 36 patients with PCNSL after exclusion of confounding vitreoretinal disease and poor‐quality OCTA scans. Eyes were classified as having ocular involvement (OI; n = 23) or no ocular involvement (NOI; n = 39), and follow‐up OCTA was available for 23 eyes from 14 patients. Macular and optic‐disc OCTA parameters were analyzed, and discriminatory performance was assessed using direction‐corrected area under the receiver operating characteristic curve (AUC). OI eyes showed predominantly deep capillary plexus (DCP)‐specific reductions in macular perfusion. DCP whole‐image inferior hemifield perfusion density was lower in OI than NOI eyes (44.95 ± 6.01% vs. 51.06 ± 6.11%; p < 0.001; AUC, 0.776), as was DCP whole‐image perfusion density (45.92 ± 6.12% vs. 51.98 ± 6.13%; p < 0.001; AUC, 0.764). In the follow‐up subset, the corresponding AUCs were 0.947 and 0.932. Neither metric showed significant within‐group changes over time, and longitudinal analyses revealed no consistent treatment‐associated perfusion pattern. These findings identify a predominantly DCP‐specific macular microvascular phenotype associated with ocular involvement in PCNSL and support DCP perfusion metrics as candidate noninvasive imaging biomarkers that may complement clinical assessment and intraocular fluid‐based evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, China.
- Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
ORCID-Profile: Qingjian Li, Zhiliang Wang, Yu Zhang
Förderung
- the Natural Science Foundation of Shanghai
Zitieren
APA
Zhu, T., Li, Q., Zhang, Y., Peng, G., Wang, Z., & Zhang, Y. (2026). Macular OCTA Biomarkers of Ocular Involvement in Patients With Primary Central Nervous System Lymphoma. Hematological Oncology, 44(6). https://doi.org/10.1002/hon.70289
Vancouver
Zhu T, Li Q, Zhang Y, Peng G, Wang Z, Zhang Y. Macular OCTA Biomarkers of Ocular Involvement in Patients With Primary Central Nervous System Lymphoma. Hematological Oncology. 2026;44(6). doi:10.1002/hon.70289
BibTeX
@article{Zhu2026,
author = {Zhu, Tianyu and Li, Qingjian and Zhang, Yuanyuan and Peng, Guichuan and Wang, Zhiliang and Zhang, Yu},
title = {Macular OCTA Biomarkers of Ocular Involvement in Patients With Primary Central Nervous System Lymphoma},
journal = {Hematological Oncology},
year = {2026},
volume = {44},
number = {6},
doi = {10.1002/hon.70289}
}
EUVIMED